Coronavirus affects clinical trials – Medicines Agency expects problems
It has "extraordinary consequences" for the conduct of clinical trials in Denmark that the country is hit by the global coronavirus pandemic, the Danish Medicines Agency writes. Pharmaceutical companies are monitoring the situation.
Pharmaceutical firms in Denmark can expect the ongoing coronavirus pandemic to entail consequences for clinical trials in the country as well, according to the Danish Medicines Agency.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
EU commission chair speaks personally to vaccine company
For abonnenter
